Archived - Applying for a Drug Identification Number (DIN) for a disinfectant drug during the COVID-19 pandemic: For more information

On this page

• Important contacts
• Other guidance documents

Important contacts

Natural and Non-prescription Health Products Directorate

Natural and Non-prescription Health Products Directorate
Health Products and Food Branch
Health Canada
250 Lanark Avenue
Address Locator 2002B
Ottawa, Ontario
K1A 0K9 (Canada Post delivery including Xpress Post)
K1Z 1G4 (Courier service excluding Xpress Post)

E-mail: nnhpd.consultation-dpsnso@hc-sc.gc.ca

eReview within Office of Submissions and Intellectual Property

E-mail: hc.ereview.sc@canada.ca

Healthy Environments and Consumer Safety Branch

E-mail: hc.ccpsa-lcspc.sc@canada.ca 

Pest Management Regulatory Agency

E-mail: pmra.subject.to.regulation-sujet.a.la.reglementation.arla@hc-sc.gc.ca

Other guidance documents

The relevant monograph and/or Labelling Standard to use is the Hard Surface Disinfectants monograph.

For information on the safety, efficacy or quality information to support application, please refer to:

• Safety and Efficacy Requirements for Hard Surface Disinfectant Drugs (2020)
• Guidance Document: Disinfectant Drugs (2020)
• Post-Drug Identification Number (DIN) Changes Guidance Document
• Guidance Document: Post-Notice of Compliance (NOC) Changes: Quality Document
• Post-Notice of Compliance (NOC) Changes: Safety and Efficacy Document

Other guidance documents and webpages that you should read in parallel to this guide include:

Submitting your application

• Regulatory Enrolment Process
• Preparation of Regulatory Activities in the “Non-eCTD Electronic-Only” Format
• Common Electronic Submissions Gateway
• Filing submissions electronically
• Guideline on Preparation of DIN Submissions
• Guidance Document: Fees for the Review of Human and Disinfectant Drug Submissions and Applications

Application streams

• Guidance Document: Regulatory requirements for Drug Identification Numbers (DINs)
• Guidance Document: Administrative Processing of Submissions and Applications Involving Human or Disinfectant Drugs
• Guidance document: Management of Disinfectant Drug Applications (2020)
• Guidance Document: Post-Drug Identification Number (DIN) Changes
• Guidance document on Post-Notice of Compliance (NOC) Changes: Framework Document (Pharmaceutical, biologic and radiopharmaceutical drugs for human use only)